Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poizat

Showing results (221-230 of 291) with videos related to

Pageof 30
Sort By:
Annals of Gastroenterology|November 29, 2023
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational studyMariola Marx, Fabrice Caillol, Sébastien Godat, et al.
Surgical Endoscopy|October 3, 2015
In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluationBertrand Napoleon, Anne-Isabelle Lemaistre, Bertrand Pujol, et al.
Brachytherapy|September 14, 2019
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancersLeonel Varela Cagetti, Christophe Zemmour, Naji Salem, et al.
Physical Chemistry Chemical Physics : PCCP|January 11, 2012
A two-step ICT process for solvatochromic betaine pyridinium revealed by ultrafast spectroscopy, multivariate curve resolution, and TDDFT calculationsStéphane Aloïse, Zuzanna Pawlowska, Cyril Ruckebusch, et al.
Annals of Gastroenterology|August 29, 2017
Impact of Full Spectrum Endoscopy® (Fuse®, EndoChoice®) on adenoma detection: a prospective French pilot studyJean-Philippe Ratone, Erwan Bories, Fabrice Caillol, et al.
Brachytherapy|May 7, 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatmentsLeonel Varela Cagetti, Laurence Moureau-Zabotto, Christophe Zemmour, et al.
Annals of Surgery|September 28, 2017
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter StudyJean Robert Delpero, Florence Jeune, Philippe Bachellier, et al.
The EMBO Journal|July 14, 2015
Huntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulationMarie-Thérèse El-Daher, Emilie Hangen, Julie Bruyère, et al.
Journal of Contemporary Brachytherapy|June 3, 2026
Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?Leonel Varela Cagetti, Julia Gilhodes, Marjorie Ferré, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 29, 2023
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French CenterJean-Philippe Ratone, Clément Archimbaud, Alexey Solovyev, et al.
Pageof 30

Showing results (221-230 of 291) with videos related to

Sort By:
Pageof 30
Annals of Gastroenterology|November 29, 2023
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational studyMariola Marx, Fabrice Caillol, Sébastien Godat, et al.
Surgical Endoscopy|October 3, 2015
In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (nCLE): proposition of a comprehensive nCLE classification confirmed by an external retrospective evaluationBertrand Napoleon, Anne-Isabelle Lemaistre, Bertrand Pujol, et al.
Brachytherapy|September 14, 2019
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancersLeonel Varela Cagetti, Christophe Zemmour, Naji Salem, et al.
Physical Chemistry Chemical Physics : PCCP|January 11, 2012
A two-step ICT process for solvatochromic betaine pyridinium revealed by ultrafast spectroscopy, multivariate curve resolution, and TDDFT calculationsStéphane Aloïse, Zuzanna Pawlowska, Cyril Ruckebusch, et al.
Annals of Gastroenterology|August 29, 2017
Impact of Full Spectrum Endoscopy® (Fuse®, EndoChoice®) on adenoma detection: a prospective French pilot studyJean-Philippe Ratone, Erwan Bories, Fabrice Caillol, et al.
Brachytherapy|May 7, 2023
The impact of brachytherapy boost for anal canal cancers in the era of de-escalation treatmentsLeonel Varela Cagetti, Laurence Moureau-Zabotto, Christophe Zemmour, et al.
Annals of Surgery|September 28, 2017
Prognostic Value of Resection Margin Involvement After Pancreaticoduodenectomy for Ductal Adenocarcinoma: Updates From a French Prospective Multicenter StudyJean Robert Delpero, Florence Jeune, Philippe Bachellier, et al.
The EMBO Journal|July 14, 2015
Huntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulationMarie-Thérèse El-Daher, Emilie Hangen, Julie Bruyère, et al.
Journal of Contemporary Brachytherapy|June 3, 2026
Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter?Leonel Varela Cagetti, Julia Gilhodes, Marjorie Ferré, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|September 29, 2023
Piecemeal Resection for Large Colorectal Adenomas Remains Essential in 2022: A Single-Center Experience in a Tertiary French CenterJean-Philippe Ratone, Clément Archimbaud, Alexey Solovyev, et al.
Pageof 30